Risk factors for a serous cancer precursor (“p53 signature”) in women with inherited BRCA mutations
- 1 November 2008
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 111 (2) , 226-232
- https://doi.org/10.1016/j.ygyno.2008.07.018
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Serous Tubal Intraepithelial Carcinoma: Its Potential Role in Primary Peritoneal Serous Carcinoma and Serous Cancer PreventionJournal of Clinical Oncology, 2008
- A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutationsGynecologic Oncology, 2008
- Updating on primary fallopian tube carcinomaActa Obstetricia et Gynecologica Scandinavica, 2007
- Society of Gynecologic Oncologists Education Committee Statement on Risk Assessment for Inherited Gynecologic Cancer Predispositions☆Gynecologic Oncology, 2007
- Association of Oral Contraceptive Use, Other Contraceptive Methods, and Infertility with Ovarian Cancer RiskAmerican Journal of Epidemiology, 2007
- Intraepithelial Carcinoma of the Fimbria and Pelvic Serous Carcinoma: Evidence for a Causal RelationshipThe American Journal of Surgical Pathology, 2007
- Reproductive risk factors for ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control studyThe Lancet Oncology, 2006
- Parity, Oral Contraceptives, and the Risk of Ovarian Cancer among Carriers and Noncarriers of aBRCA1orBRCA2MutationNew England Journal of Medicine, 2001
- Tubal ligation and risk of ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control studyThe Lancet, 2001
- Absence of premalignant histologic, molecular, or cell biologic alterations in prophylactic oophorectomy specimens fromBRCA1 heterozygotesCancer, 2000